Concepedia

Yingluo Liu

YL

Statistics

Publications

8

Citations

542

H-Index

8

Active since

2019

Affiliations

Shanghai Institute of Materia Medica(Current)

University of Chinese Academy of Sciences

Chinese Academy of Sciences

Nanjing University of Chinese Medicine

Xiamen University

Yingluo Liu is an author at Shanghai Institute of Materia Medica specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2019–2025

8

Publications

8

Bile acid synthesis impedes tumor-specific T cell responses during liver cancer

Siva Karthik Varanasi, Dan Chen, Yingluo Liu et al. · Science · 2025 · 147 citations · Full text

, , +17

Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

Nan Jin, Aiwei Bi, Xiaojing Lan et al. · Nature Communications · 2019 · 143 citations · Full text

, , +17

Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Xuewu Liang, Shuai Tang, Xuyi Liu et al. · Journal of Medicinal Chemistry · 2021 · 67 citations · Full text

, , +13

SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors

Xiaomin Wang, Ziqi Chen, Jun Xu et al. · Cell Research · 2022 · 58 citations · Full text

, , +16

A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies

Zhiwei Liu, Yingluo Liu, Lili Qian et al. · Molecular Cell · 2021 · 55 citations

, , +12

1–5 of 8